Daiichi Sankyo

Daiichi could be rewarded for persisting with Vanflyta
EP Vantage
Fri, 11/19/21 - 10:49 am
Daiichi Sankyo
Vanflyta
AML
Daiichi jettisons ADC after flunking early solid tumor test
Fierce Biotech
Fri, 10/29/21 - 10:34 am
Daiichi Sankyo
antibody-drug conjugate
GIST
DS-6157
solid tumors
Feeling Collaborative, Merck Inks Three More Deals to Strengthen Portfolio
BioSpace
Tue, 10/26/21 - 12:01 am
Merck
Keytruda
Xeris Biopharma
XeriJect
Evaxion Biotech
EVX-01
Daiichi Sankyo
AstraZeneca
datopotamab deruxtecan
Enhertu nabs speedy FDA review for earlier use in breast cancer
Pharmaforum
Mon, 10/4/21 - 10:57 am
AstraZeneca
Daiichi Sankyo
Enhertu
breast cancer
FDA
ESMO 2021 movers – a handful of biotech winners emerge
EP Vantage
Fri, 09/24/21 - 11:48 am
ESMO
Corbus Pharmaceuticals
Leap Therapeutics
Surface Oncology
AstraZeneca
Innate Pharma
Immunocore
Daiichi Sankyo
Verastem
Spectrum Pharrmaceuticals
Mirati Therapeutics
AstraZeneca, Daiichi Sankyo's ADC Enhertu blows away Roche's Kadcyla in second-line advanced breast cancer
Endpoints
Sat, 09/18/21 - 08:34 pm
ESMO
AstraZeneca
Daiichi Sankyo
Enhertu
breast cancer
Roche
ESMO: Daiichi unveils first early peek at next-gen ADC as analysts see strong data against rivals
Fierce Biotech
Fri, 09/17/21 - 11:06 am
ESMO
Daiichi Sankyo
antibody-drug conjugate
DS-7300
AstraZeneca and Daiichi Sankyo continue to flesh out Enhertu plans, claiming win in earlier breast cancer line
Endpoints
Mon, 08/9/21 - 10:55 am
AstraZeneca
Daiichi Sankyo
Enhertu
breast cancer
Novartis to pay nearly $178M in lawsuit over BRAF drug — and will be on the hook for royalty
Endpoints
Fri, 07/23/21 - 10:57 am
Novartis
patents
Tafinlar
Plexxikon
Daiichi Sankyo
AstraZeneca, Daiichi Sankyo uncork new TNBC data for 2nd partnered ADC — and it's adding more heat under Gilead's Trodelvy
Endpoints
Sun, 05/9/21 - 10:58 pm
AstraZeneca
Daiichi Sankyo
TNBC
antibody-drug conjugate
Daiichi exits combo vaccine pact with Sanofi after pertussis shot manufacturing glitches
Fierce Pharma
Wed, 03/31/21 - 10:53 pm
Daiichi Sankyo
Sanofi
vaccines
VN-0105
pertussis
drug manufacturing
Daiichi takes mRNA COVID-19 vaccine into clinic as Japanese R&D belatedly fires up
Fierce Biotech
Mon, 03/22/21 - 10:37 am
Daiichi Sankyo
MRNA
COVID-19
vaccines
Japan
AZ/Daiichi Sankyo’s Enhertu gets second US cancer indication
Pharmaforum
Mon, 01/18/21 - 01:15 pm
AstraZeneca
Daiichi Sankyo
stomach cancer
Enhertu
Roche
Herceptin
Sanofi inks COVID-19 mRNA vaccine deal with Translate BioDaiichi Sankyo’s Mirogabalin Displays Significant Reduction in Post-SCI Neuropathic Pain
BioSpace
Sat, 12/19/20 - 11:22 pm
Daiichi Sankyo
gabapentinoid
central neuropathic pain after spinal cord injury
spinal cord injury
Daiichi Sankyo takes oncology shift into next phase with new global business unit
Fierce Pharma
Mon, 11/23/20 - 10:34 pm
Daiichi Sankyo
oncology
Enhertu picks up another win for AstraZeneca and Daiichi Sankyo, joining the priority review lane for gastric cancer
Endpoints
Wed, 10/28/20 - 10:32 am
AstraZeneca
Daiichi Sankyo
Enhertu
breakthrough status
FDA
metastatic gastric cancer
gastric cancer
Daiichi Sankyo, AstraZeneca collaborate to evaluate patritumab deruxtecan in combination with TAGRISSO in EGFR-mutated NSCLC
Pharmaceutical Business Review
Fri, 08/7/20 - 11:10 am
Daiichi Sankyo
AstraZeneca
patritumab deruxtecan
Tagrisso
non-small cell lung cancer
clinical trials
4 Reasons AstraZeneca Gave Daiichi Sankyo Another $1 Billion Upfront
Motley Fool
Tue, 07/28/20 - 11:14 am
AstraZeneca
DS-1062
Daiichi Sankyo
AstraZeneca inks $6bn cancer drug deal with Daiichi Sankyo
Pharmaforum
Mon, 07/27/20 - 11:00 am
AstraZeneca
Daiichi Sankyo
DS-1062
antibodies
cancer
Daiichi Sankyo expands DS-1062 study to include patients with triple negative breast cancer
Pharmaceutical Business Review
Thu, 07/2/20 - 11:09 am
Daiichi Sankyo
antibody-drug conjugate
triple negative breast cancer
DS-1062
clinical trials

Pages